Incidence of Infections in Adult Patients (> 55 Years) with Acute Myeloid Leukemia Treated with Yeast-Derived GM-CSF (Sargramostim): Results of a Double-Blind Prospective Study by the Eastern Cooperative Oncology Group

This publication has 14 references indexed in Scilit:

• Risk Factors for Fungal Infection in Patients with Malignant Hematologic Disorders: Implications for Empirical Therapy and Prophylaxis
  Clinical Infectious Diseases, 1994
• The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen‐year period
  British Journal of Haematology, 1993
• Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
  Journal of Clinical Oncology, 1992
• Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid Cancer
  New England Journal of Medicine, 1991
• Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation
  Blood, 1990
• Granulocyte-Macrophage Colony-Stimulating Factor Augments Human Monocyte Fungicidal Activity for Candida albicans
  The Journal of Infectious Diseases, 1990
• Treatment of acute myeloid leukemia in elderly patients.A retrospective study
  Cancer, 1988
• Infection in cancer patients: A continuing association
  The American Journal of Medicine, 1986
• Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study
  Blood, 1982
• Causes of initial remission induction failure in acute myelogenous leukemia
  Blood, 1982